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Mathematical models can help us to understand complex molecular mecha-
nisms underlying diseases. There is a lack of these types of models describing
the cellular processes involved in conditions such as insulin resistance and Type
2 diabetes (T2D). Therefore, this study aimed to quantify the reference state
of the insulin signalling pathway for the construction of a mathematical model
describing the dynamics of the pathway intermediates. This model will serve
as a comparison for a model describing the diabetic state. Western blot anal-
ysis was used to quantify the phosphorylation states of Akt Ser473 and Thr308
at varying concentrations of insulin and over time, with or without insulin.
The glucose transporter, GLUT4, activity was also investigated at dierent
concentrations of insulin. These data were used in the construction of a model
for the reference state. Ordinary dierential equations (ODEs) were derived
to describe the dynamics of Akt over time. Steady state constraints were used
to t the dose response for Akt and made it possible to estimate a dephospho-
rylation/phosphorylation ratio. The estimated ratio was used to determine if
the model could describe the time course data. A similar analysis was done




and dephosphorylation dynamics of the Akt Ser473 and Thr308 site. In order to
determine the link between insulin signalling and glucose transport, transport
activity was plotted against Akt phosphorylation and the model was tted to
this data. The t for both the Ser473 and Thr308 site did not dier. We found
that the model predictions correlated quite well with the experimental data
despite the lack of data on intermediates between insulin and Akt.
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Wiskundige modelle kan ons help om komplekse molekulêre meganismes on-
derliggend aan siektes te verstaan. Daar is 'n gebrek aan hierdie tipe modelle
wat die sellulêre prosesse beskryf wat betrokke is by toestande soos insulien-
weerstandigheid en Tipe 2 diabetes (T2D). Daarom het hierdie studie ten doel
gehad om die verwysingstoestand van die insulien seinepad te kwantiseer vir
die konstruksie van 'n wiskundige model wat die dinamika van die tussengan-
gerselprodukte beskryf. Hierdie model sal as vergelyking dien vir 'n model
wat die diabetiese toestand beskryf. Western blot analise is gebruik om die
fosforileringstoestande van Akt Ser473 en Thr308 te kwantiseer by verskillende
konsentrasies insulien en met verloop van tyd, met of sonder insulien. Die
glukosetransporter, GLUT4, is ook by verskillende konsentrasies insulien on-
dersoek. Hierdie is gegewens gebruik vir die konstruksie van 'n model vir die
verwysingstoestand. Gewone dierensiaalvergelykings (ODE's) is afgelei om
die dinamika van Akt oor tyd te beskryf. Gereelde beperkings is gebruik om
by die dosisrespons vir Akt te pas en het dit moontlik gemaak om 'n defosfo-
rilering / fosforilasie-verhouding te skat. Die beraamde verhouding is gebruik




analise is vir GLUT4 gedoen. Die model kon die fosforilering en defosforile-
ring dinamika van die Akt Ser473 en Thr308 akkuraat beskryf. Ten einde die
verband tussen insulien seine en glukose vervoer te bepaal, is vervoeraktiwi-
teit teen Akt fosforilering geplot en die model was op hierdie date gepas. Die
pas vir beide die Ser473 en Thr308 verhouding met GLUT4 het nie verskil nie.
Ons het gevind dat die modelvoorspellings redelik goed met die eksperimentele
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Type 2 diabetes (T2D) is a metabolic disease that negatively impacts the
health of many individuals worldwide. It accounts for 90-95% of diabetes cases
[1] and the World Health Organization (WHO) reported 1.5 million deaths
caused by diabetes in 2012 and in 2014 it was estimated that 422 million peo-
ple suer from diabetes [2]. Unlike Type 1 diabetes, which is usually caused
by an autoimmune disorder that attacks pancreatic β-cells, T2D is thought
to be the result of insulin resistance (often associated with obesity) [1]. This
disease is characterised by glucose intolerance, hyperinsulinemia and insulin
resistance in peripheral tissues such as skeletal muscle, adipose tissue and the
liver [3]. When left untreated T2D can cause irreversible damage to organs
and puts individuals aected by this condition at higher risk for strokes, car-
diovascular disease, kidney failure, vision loss, nerve damage and many other
complications [4]. Typically T2D is treated with lifestyle changes such as diet
and exercise as well as drugs like metformin which helps regulate blood glucose
levels [5]. Metformin has been used for over 50 years to treat T2D and is known
to lower the production of glucose and increase glucose utilization. However,
the exact mechanism whereby metformin elicits these eects remains poorly
understood, and this drug is not without its side eects [6]. Lifestyle changes
and drugs are helpful to reduce blood glucose levels to normoglycemia, but
cannot reverse the damage that has already been done to tissues and organs.
It is necessary to investigate the cellular mechanisms underlying conditions
such as insulin resistance and T2D to understand the extent of the metabolic
dysfunction. There are three main tissues implicated in T2D, skeletal muscle,
1
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adipocytes and the liver. Of these three, skeletal muscle is responsible for
± 75% of insulin-dependent glucose uptake [7] and is therefore important for
maintaining glucose homeostasis. To understand how insulin regulates glucose
uptake, further investigation into the dynamics of the insulin signalling path-
way is required. Dysregulation in this pathway can lead to insulin resistance
and T2D. There is still uncertainty as to the precise molecular mechanisms
underlying these medical conditions. The insulin signalling pathway is com-
plex with a large degree of crosstalk between the signalling intermediates. This
is further complicated considering that each of these proteins are phosphory-
lated and dephosphorylated at multiple sites in response to insulin and various
components from other signalling pathways (Fig. 1.1). This complexity hin-
ders progress when it comes to understanding diseases like T2D. Mathematical
models can help us to elucidate such complex systems, to identify new drug
targets and to test new drugs.
The structure of the insulin signalling pathway is well known, however,
there is a lack of kinetic mechanistic models describing the dynamics of this
pathway. This project forms part of a larger goal to have a mathematical model
for Type 2 diabetes that consists of three compartments namely: insulin sig-
nalling, glucose transport, and glucose metabolism. To achieve this we rst
need to establish the dynamics of the reference state, which in this case refers
to cells that are not insulin resistant or diabetic. Although the components of
the pathway are well known, the dynamic and kinetic behaviour still needs to
be elucidated. There is a lack of data in literature that describes the dose and
time dependent behaviour of the pathway intermediates. To understand what
complications arise on a molecular level during insulin resistance and T2D we
rst need to determine the behaviour of the pathway under healthy physiolog-
ical conditions after which we will have a model to compare the diabetic state
to.
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This led us to the following research question:
1. Can we construct a mathematical model that describes the insulin sig-
nalling pathway dynamics and link this to glucose transport?
The aim of this thesis is therefore to come to a quantitative description of
the insulin signalling pathway and its link to glucose transport induction of
the reference state. In this project rat skeletal muscle cells are used but the
techniques and analyses can be extended to other cell lines in future studies.
This reference state will serve as a control in a follow up study in insulin
insensitive cells, to determine where changes have occurred, leading to the
reduced insulin response. To achieve this aim the following objectives were
set:
 Determine the phosphorylation levels of key intermediates in the insulin
signalling pathway at varying insulin concentrations.
 Determine the phosphorylation and dephosphorylation of key intermedi-
ates in the insulin signalling pathway upon insulin stimulation/ removal
over time.
 Determine the glucose transport dynamics at varying doses of insulin as
well as over time with the addition or removal of insulin.
 Construct a mathematical model that describes the reactions of the in-
sulin signalling pathway.
The thesis is structured as follows: Firstly in Chapter 2, I will be discussing
the important literature related to T2D and mathematical modelling. Chapter
3 follows with the methodologies used to perform the experiments presented
in this thesis. The results are presented in Chapter 4, starting with an op-
timization section after which the results of the phosphorylation and glucose
transporter experiments are presented. Chapter 4 ends with the model de-
scription and results obtained from the model. Chapter 5 serves as a general
discussion and conclusion chapter.
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Insulin is the most important hormone for maintaining glucose homeostasis
in the body [8]. When blood glucose levels rise, insulin is secreted from the
pancreatic beta cells into the blood stream. The secretion of insulin stimulates
the uptake of glucose primarily into the muscle and adipose tissue, where it is
stored as glycogen and triglycerides respectively (see Fig. 2.1) [8]. Simultane-
ously, insulin also acts on the liver to prevent it from producing more glucose
by inhibiting processes such as gluconeogenesis and glycogenolysis, which fur-
ther prevents increases in blood glucose levels after a meal [8]. However, when
target tissues fail to respond to normal levels of circulating insulin a condition
known as insulin resistance develops [9]. Insulin resistance is considered the
precursor to more serious diseases such as T2D. One of the rst abnormalities
observed during insulin resistance is the decrease in insulin dependent glucose
uptake by striated muscle tissue and adipocytes, as well as the decrease in the
ability of insulin to suppress glucose production by the liver [9]. The onset of
T2D is characterised by consistently high blood glucose concentrations, which
persist despite moderate to high levels of insulin present in the bloodstream [8].
As T2D progresses, the ability of the pancreatic beta cells to secrete insulin is
exhausted and this leads to low levels of insulin in blood circulation, calling
for exogenous insulin to be administered [8]. Due to the blood glucose levels in
T2D patients remaining persistently high over many years, clinical complica-
tions such as cardiovascular disease, retinopathy, neuropathy and nephropathy
develop, contributing to the morbidity and mortality of this disease [8]. The
5
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high incidence of T2D along with its serious complications, makes it vital to
understand the molecular mechanisms of insulin dependent glucose transport
as well as insulin resistance [8]. In this literature review I will focus on the var-
ious components of the insulin signalling pathway and how these components
interact with one another. The eect of insulin resistance on this pathway
will also be discussed as well as why L6 rat skeletal muscle cells serve as a
model system for studying the insulin signalling pathway. Finally, a section
on systems biology will be included reviewing some mathematical models that
describe the insulin signalling pathway.
Figure 2.1: The stimulatory and inhibitory eects of insulin on pro-
cesses carried out by dierent tissues. This image was created in Wolfram
Mathematica® using the AnatomyPlot3D function.
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2.2 The Insulin Signalling Pathway
The binding of insulin to membrane-bound receptor proteins initiates the in-
sulin signalling pathway in mammalian cells (see Fig. 2.2). These receptors are
tetramers, which consist of extracellular (two α-subunits) and transmembrane
(two β-subunits) monomeric components [10]. Insulin binds to the α-subunit,
which activates the intrinsic kinase activity of the β-subunit. This leads to
one β-subunit tyrosine, phosphorylating an adjacent β-subunit (intramolecular
transautophosphorylation) [8]. The insulin receptor substrate (IRS) contains
a phosphotyrosine binding (PTB) module that interacts with phosphorylated
IR, which then phosphorylates IRS on various tyrosine residues [11].
Regulatory subunits such as p85 with Src Homology 2 (SH2) use the phos-
phorylated tyrosine residues on IRS as docking sites. This regulatory subunit
exists as a dimer in the cytosol and is composed of a regulatory subunit, p85
and a catalytic subunit p110α 
p85 is the most important regulatory subunit
of Type IA phosphatidylinositol 3' kinase (PI3K) [12]. Recruitment of the
regulatory subunit to the membrane allows the catalytic subunit p110α to
catalyse the phosphorylation of phosphoinositide (PI) lipids in the 3' position
of the inositol ring. This reaction allows for the phosphorylation of phos-
phatidylinositol 4,5-bisphosphate (PIP2) to form the second lipid messenger
phosphatidylinositol (3,4,5)-triphosphate (PIP3) [10]. The phosphorylation of
the PIP proteins allows for the recruitment and downstream activation of Akt
also known as Protein Kinase B (PKB). Proteins containing an N-terminal
pleckstrin homology (PH) domain, such as Akt, have a high innity for PIP3
[13].
The recruitment of Akt via PIP3 to the membrane allows for a conforma-
tional change in Akt which leads to the phosphorylation of the Thr308 residue
which is situated in the activation segment of Akt. Phosphorylation of the
Thr308 site is facilitated through a membrane-localized 3-phosphoinositide-
dependent kinase 1 (PDK1) leading to partial activation of Akt [13]. Full
activation of Akt is achieved by phosphorylation of Ser473 site, which is situ-
ated in the hydrophobic motif, through mammalian target of rapamycin com-
plex 2 (mTORC2) [14]. A GTPase-activating protein (GAP) (Akt substrate of
160kDa (AS160)) is activated by Akt downstream. AS160 contains a GTPase-
activating domain for a Rab. Rab proteins have been identied to be involved
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in vesicle tracking [15]. GLUT4 is a glucose transporter responsible for
insulin stimulated glucose uptake, and is known to be arranged in vesicles.
Phosphorylated AS160 therefore allows GLUT4 containing vesicles (GSVs) to
translocate to the plasma membrane [13] which then fuses with the membrane
to facilitate glucose transport.
2.2.1 Insulin
In healthy individuals plasma glucose concentrations can vary between 4 and
7 mM, even during periods of feeding and fasting. This narrow concentration
range is regulated by dierent processes occurring within the body, including
absorption of glucose in the intestine, production of glucose by the liver as
well as the metabolism and uptake of glucose by peripheral tissues [7]. Blood
glucose homeostasis is primarily regulated by insulin which represses glucose
production in the liver, and stimulates glucose uptake in muscle and fat tissues
[7, 16]. Insulin also stimulates protein synthesis in the muscle, fatty acid uptake
in adipose tissue and glucose utilization and triglyceride synthesis in the liver.
In addition, it supresses glucose synthesis and inhibits lipolysis in the liver and
adipose tissue, respectively [16, 17]. Energy storage and utilisation is increased
by insulin via GLUT4. The increase in glucose uptake is due to the increasing
levels of GLUT4 at the membrane and not an increase of intrinsic GLUT4
activity [18]. For this reason, insulin is thought to be one of the most important
negative regulators of its own signalling. Furthermore, it has been shown that
if insulin concentration in the blood stays consistently high, also known as
hyperinsulinemia, IR internalises and undergoes lysosomal degradation or is
recycled back to the membrane [19], leading to a decrease in insulin signalling.
This is thought to be the basis of the concept that hyperinsulinemia and insulin
resistance are associated. This can be promptly reversed through fasting,
allowing plasma insulin levels to fall [16]. Insulin carries out essential functions
within the body and the cascade of signals involved in these functions include
many intermediates with many interactions, therefore it is important to be
able to identify critical nodes in these signalling cascades.
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(a)
(b)
Figure 2.2: Schematic of the insulin signalling pathway without in-
sulin bound (a) and insulin bound (b). Insulin (green) binds to IR (blue)
which leads to a conformational change in IR allowing transautophosphory-
lation. Phosphorylated IR then phosphorylates IRS (yellow) which leads to
the recruitment of the regulatory subunit of PI3K (purple) to the membrane.
This allows for the catalytic subunit of PI3K to phosphorylate lipids in the
membrane, leading to recruitment and downstream phosphorylation of Akt
(orange). Phosphorylated Akt leads to the recruitment of GSVs (sphere con-
taining cylinders(GLUT4) to the membrane where it docks and fuses with the
membrane leading to increasing concentrations of GLUT4 (grey cylinders) at
the membrane, allowing increased glucose uptake. This image was created by
the author in Wolfram Mathematica using the 3DPlot function.
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2.3 Critical nodes in signalling pathways
Taniguchi et al. [20] proposes three criteria for a signalling intermediate to be
classied as an essential mediator or a 'critical node'. The rst criteria states
that the node should constitute more than one isoform of a protein and that
these dictate the receptor-mediated signal. In addition, these isoforms should
full unique biological functions to introduce a degree of divergence to the
signalling pathway. Secondly, the possible critical node has to be governed by
positive and negative feedback systems. The last criteria is that the potential
critical node needs to act as a point for crosstalk between dierent signalling
pathways. Taniguchi et al. [20] used the insulin signalling pathway as an
example for this analysis and identied three critical nodes that suit the above
mentioned criteria. These nodes are of the IR and IRS, P13K and lastly Akt
(Fig. 2.2). Each one of these nodes will be discussed in detail below as well as
one of the downstream mediators of Akt, namely GLUT4.
2.3.1 IR and IRS
The IR is a tetrameric protein with two extracellular α and two intracellular
β- subunits. The IR forms part of a subfamily of receptor tyrosine kinases
(RTKs), which also includes the insulin-like growth factor 1 receptor (IGF1R)
and IR-related receptor (IRR) [21]. IR acts as a classical allosteric enzyme
in which the tyrosine-kinase activity intrinsic to the β-subunit is inhibited by
the α- subunit. This inhibition can be lifted when insulin binds to the α-
subunit or the subunit is removed by genetic deletion or proteolysis, thereby
activating the kinase activity of the β-subunit [22]. Initial activation of β-
subunits allows for the transphosphorylation of the β- subunits, inducing a
conformational change which further increases its kinase activity [20]. Two
isoforms of IR exist, namely IRA and IRB. The more metabolically active
isoform, IRA, functions in the foetus as a growth-promoting isoform, while
IRB on the other hand is less active but is predominantly expressed in adult
liver [23]. Both isoforms are expressed in the liver, muscle- and adipose tissue,
but IRB is more predominantly expressed than IRA[24].
Eleven intracellular substrates have been identied for IR and IGF1R, with
IRS constituting six of these substrates (summary in Table 2.1) [20]. Proteins
that contain an SH2 domain use the phosphorylated tyrosine residues on IRS
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as docking sites, for example, adapter proteins such as p85 the regulatory sub-
unit of PI3K. Binding of substrates to adapter proteins can inuence their
subcellular location as well as their activity [7]. The homologs of IRS can have
dierent functions depending on the subcellular localisation, dierent tissue
distribution as well as intrinsic activity of these proteins [16]. For example,
studies in mice involving gene knockouts (KO) have given clarity to the func-
tions of the dierent IRS isoforms. Araki et al. [25] showed that IRS1 KO
mice have impaired insulin action in muscle and exhibit growth retardation,
however show normal glucose tolerance, whereas IRS2 KO mice displayed ab-
normalities regarding insulin signalling in the liver [26]. IRS1 and IRS2 KOs in
pre-adipocytes lead to defects in dierentiation and disruption of insulin stim-
ulated glucose transport [27, 28]. IRS1 is necessary for glucose metabolism
and myoblast dierentiation in skeletal muscle cells, whereas IRS2 is crucial
for ERK activation and lipid metabolism [29, 30]. IRS3 and IRS4 exhibit
limited tissue distribution. IRS3 is the most abundant in rodents in lung,
adipocyte and liver tissue. Humans lack IRS3, as it is expressed as a pseu-
dogene where no product is produced [10, 16]. IRS3 KO mice do not seem
to possess abnormalities, but when combined with IRS1 KO exhibit extreme
defects in adipogenesis [31]. IRS4 is present in various tissues, such as brain,
heart, kidney, liver and skeletal muscle. IRS4 KO mice did not have any severe
defects except for minimal glucose intolerance and growth retardation [32, 33].
The last two homologs, IRS5 and -6 also known as DOK4 and DOK5 have
poor tissue expression and are poor substrates for the IR [34, 35].
2.3.2 PI3K
PI3K phosphorylates PI, PIP and PIP2 on the 3-hydroxyl group of the inositol
ring. These phosphoinositides control the function and localisation of various
eector proteins that bind these lipids via specic lipid-binding domains. PI3K
contributes to many processes at cellular level, including cell growth, migra-
tion and survival, intracellular vesicular transport and cell cycle progression.
There are many isoforms of PI3K which have been grouped into three classes
(class I-III) (summary in Table 2.2) based on lipid substrate preferences and
structural features. Although the general signalling of PI3K has been eluci-
dated, the specic roles of the dierent isoforms are still unclear [39]. The class
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lung, brain, liver, kidney,
heart and spleen
glucose homeostasis,













This table was composed from the following references: [11], [32], [34], [36], [37], [38].
I PI3Ks function as heterodimers consisting of one catalytic subunit (p110α,
β, δ or γ) and one regulatory subunit (p85α (or its splice variants p50α and
p55α), p85β, p55γ, p84 or p101) [40]. The catalytic subunit is also divided into
two classes, class IA (p110α, p110β and p110δ) and class IB (p110γ). The class
IA catalytic subunits bind the p85 regulatory subunit type, whereas class IB
on the other hand binds two other regulatory subunits, namely, p101 and p84
[41]. The p85 regulatory subunit contains SH2 domains which allows it to bind
phosphorylated tyrosines. Binding of p85 to phosphorylated tyrosine residues
lifts the p85-mediated inhibition of p110 isoforms bringing them closer to their
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Table 2.2: Various isoforms of PI3K and their functions.
Classes Subunit Type Tissue distribution









Class II PI3KC2α catalytic ubiquitous
PI3KC2β
PI3KC2γ restricted
Class III VPS34 catalytic ubiquitous
This table was composed from the following references:[12], [40], [43], [39].
lipid substrates in the membrane [39]. The physiological and signalling roles
of the class II PI3Ks are still poorly understood. They were discovered due
to their high sequence homology with class I and III PI3Ks. Three isoforms
of class II PI3Ks exist in mammals; namely, PI3K-C2α, PI3K-C2β and PI3K-
C2γ, of which the rst two isoforms are ubiquitously expressed in tissues and
the third isoform seems to have more restricted tissue distribution [42]. The
third class of PI3Ks contains only one isoform known as VPS34. In mam-
mals, the biological function of VPS34 is thought to involve the regulation of
vesicle trac, including endocytosis, autophagy and phagocytosis [39]. The
involvement of class III PI3Ks in signal transduction is yet to be elucidated.
2.3.3 Akt
Akt/PKB are serine/threonine protein kinases that have various regulatory
functions, including metabolism of protein, lipids and carbohydrates as well as
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control of cell proliferation, growth, survival, apoptosis and angiogenesis [44].
Three isoforms of Akt exist, namely Akt1-3, where Akt1 and Akt2 are highly
expressed in skeletal muscle. However, there seems to be two factors that
play a role in their specicity for insulin signalling: intracellular localization
as well as their relative abundance. Many studies have shown that the Akt2
isoform plays a predominant role in mediating glucose homeostasis, whereas
Akt1 and Akt3 are important for growth and brain development respectively
[10, 16]. In addition, studies involving murine models have also found that
AKT2 KO mice exhibited hyperinsulemia, glucose intolerance, hyperglycemia,
and impeded glucose uptake in muscle and adipose tissue, however AKT1 and
AKT3 KO mice did not display these traits [45]. Furthermore, in vitro studies
have also shown a specic mechanism by which Akt2 specically promotes
GLUT4 translocation due to Akt2 being enriched at the plasma membrane in
response to insulin. However, this eect was not observed for Akt1 [44, 45].
Recently, it was also demonstrated that GLUT4 translocation is still preserved
when the kinase activity of either Akt1 or Akt2 is acutely inhibited. This
indicates that both isoforms are sucient and previous results were based
on long term Akt2 depletion and not on catalytic activity. However, Akt1
has been shown to be a necessity for adipogenesis, conrming that some Akt
functions require specic isoforms [46].
2.3.4 GLUT4
The transport of glucose is facilitated through a group of solute carriers re-
ferred to as the GLUT family. These solute carriers are distributed in various
tissues, possess dierent sugar specicities and have unique kinetic properties.
There are 13 members of the GLUT family (GLUT1-12), including a myo-
inositol transporter HMIT1 [8]. Four of these transporters, belonging to the
class I glucose transporters (GLUT1-4), have been characterised in detail [47].
GLUT1 is responsible for basal glucose uptake and is ubiquitously expressed.
GLUT2 is predominantly expressed in β-cells and the liver, and exhibits a low
anity for glucose. GLUT2 together with hexokinase forms part of the glu-
cose sensor. The GLUT3 isoform is expressed in neurons of adults and during
fetal development and has a relatively high anity for glucose [8]. Similar to
the other GLUT members, GLUT4 is specic in its tissue distribution and
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functionality. GLUT4 is mainly expressed in fat and muscle and is responsible
for insulin stimulated glucose uptake [16]. Insulin promotes the translocation
of GLUT4 from intracellular storage sites to the plasma membrane through
IR and subsequent reactions in the signalling pathway. Insulin is responsi-
ble for a number of steps involved in the movement of GLUT4, including the
synthesis of GLUT4 containing vesicles as well as the docking and fusion of
these vesicles to the plasma membrane [48, 49]. The regulation of these steps
happen downstream of Akt and are mediated by dierent eectors. AS160 is
the best described substrate of Akt essential for GLUT4 translocation. The
phosphorylation of AS160 via Akt leads to the inactivation of its GAP ac-
tivity, consequently activating RAB proteins targeted by AS160 [15, 49, 50].
The primary RAB isoform in muscle cells is RAB8a and RAB10 in fat cells.
RAB10 has been shown to be responsible for approximately half of insulin's
eect on GLUT4 [5153]. RAB10 elicits its function at a step before vesicle
docking, and recently it was demonstrated that RAB10 could be involved in
the synthesis of vesicles containing GLUT4 [54]. Therefore, proteins responsi-
ble for vesicle docking and fusion are likely to be independent of AS160 and
RAB10.
2.4 Insulin resistance and insulin signalling
The mechanisms of regulation for both IR and IRS are very similar. Both
are activated by tyrosine phosphorylation and negatively regulated by serine
phosphorylation, protein tyrosine phosphatases (PTPs) and ligand-induced
downregulation [20]. Several mechanisms of negative regulation exist, one of
which is a class of PTPs; namely PTP1B. PTP1B reduces the kinase activity of
IR by interacting with the receptor leading to dephosphorylation of important
tyrosine residues [20]. In vivo KO studies of PTP1B showed enhanced insulin
signalling resulting in improved insulin sensitivity [55]. Downregulation of IR
function by proteins such as growth factor receptor- bound protein 10 (Grb10),
suppressor of cytokine signalling-1 (SOCS1) and SOCS3 and plasma cell mem-
brane glycoprotein-1 (PC1) work through hindering IR crosstalk between IR
and IRS or through the modication of IR kinase activity [56]. The SOCS
proteins are of interest as they have been implicated in insulin resistance and
could contribute to the pathophysiology of diabetes [57].
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Another form of negative IR regulation happens at protein level where the
receptor undergoes ligand-stimulated internalisation and degradation. This is
a common occurrence in insulin resistant or hyperinsulinaemic states such as
T2D and obesity [58]. The negative regulation of IRS proteins through serine
phosphorylation can be brought about by insulin, cytokines, free fatty acids
and other stimuli [59]. IRS1 has multiple serine phosphorylation sites, and
generally it would appear that serine phosphorylation is a negative regulator
of IRS1. In insulin resistant states serine phosphorylation of IRS1 is increased
and this is thought to play a role in insulin resistance. IRS kinases are activated
by insulin [6062], this indicates that there might be a negative feedback loop
for the insulin signalling pathway via IRS serine phosphorylation.
It has been shown that the activation of nuclear factor (NF)-κB medi-
ated pathways can inhibit insulin signalling through IRS1 serine phosphory-
lation. This indicates that IRS serine phosphorylation might be a mechanism
of crosstalk between signalling pathways [20, 63]. However, precisely how ser-
ine phosphorylation inuences the function of IRS1 remains unclear, although
it has been suggested that the phosphorylated serine sites interfere with the
functional domains in which IRS1 resides [6467]. Moreover, despite evidence
for a strong correlation between serine phosphorylation of IRS1 and insulin
resistance the exact mechanisms involved in the pathophysiology of insulin re-
sistance requires further investigation. The signicance of phosphorylation of
serine sites located on other IRS isoforms also remains understudied, especially
the potential regulation this process may have on insulin resistance [20]. Fur-
thermore, expression levels of IRS may also be important for the regulation of
this protein. A decrease in IRS1 and IRS2 expression levels has been shown in
vivo and in vitro in hyperinsulinemic states, however the mechanism leading to
the downregulation of protein expression levels has not yet been determined.
It could be possible that hyperinsulinemia degrades IRS1 and inhibits IRS2
synthesis at transcriptional level [68]. Another possibility might include the
ubiquitin-mediated degradation of IRS1 and IRS2 induced by SOCS proteins
[69]. Although the mechanisms underlying the decreased levels of IRS pro-
teins are unclear, overall decreases in both IR and IRS levels contribute to the
observed insulin resistant and diabetic phenotypes [20, 70].
Several mechanisms are thought to be responsible for the negative regula-
tion of the insulin signalling pathway via PI3K. The ratio between the regula-
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tory and catalytic subunits represents one such mechanism [71]. A high ratio
of p85 monomers compared to p85-p110 heterodimer, competes for binding to
phosphorylated IRS proteins. Therefore a reduction in p85 monomer should
increase insulin action as this would allow more p85-p110 heterodimers to bind
to phosphotyrosines on IRS. However, this mechanism provides no explanation
for negative eects related to the regulatory subunit as overexpression of p50α
or p55α did not result in similar decreases of insulin action compared to that of
the p85 regulatory subunit [72]. Two other mechanisms are suggested that can
possibly explain the full extent of p85 negative regulation. The rst proposed
mechanism involves the compartmentalisation and or sequestration of PI3K
activity [20]. Luo et al. [73] showed that monomeric p85 regulatory subunits,
but not isoforms of the regulatory subunit, isolated IRS and PI3K activity into
cellular foci that are unable to produce PIP3. The second mechanism might
involve crosstalk between the stress-pathway and p85 subunit, however this
will not be discussed here. Negative regulation via p85 regulatory subunit and
not via other isoforms of the regulatory subunit, may indicate that structural
dierences account for functional dierences [20].
Various inhibitory molecules such as PH-domain leucine-rich repeat pro-
tein phosphatase (PHLPP) and protein phosphatase-2A (PP2A) regulate Akt
activity by directly dephosphorylating Akt [74, 75]. Tribbles-3 (TRB3) is also
a regulator of Akt and elicits its function through binding unphosphorylated
Akt which inhibits its phosphorylation and activation [76]. In fasting mice, an
upregulation in TRB3 levels occurs along with increased hepatic glucose out-
puts when TRB3 is overexpressed. However, insulin sensitivity is improved by
RNAi-mediated downregulation of TRB3 [77]. Another feedback mechanism
has been suggested for the inhibition of Akt [78]. It involves an inositol py-
rophosphate known as diphosphoinositol pentakisphosphate (IP7). IP7 binds
to the PH domain of Akt, leading to the inability of PDK-1 to phosphorylate
the Thr308 site of Akt. This leads to a decrease in insulin stimulated glucose
uptake in adipose and muscle tissue [78, 79].
2.5 L6 muscle cells as a model system
Skeletal muscle are among the most important tissues involved in insulin-
dependent glucose uptake and is therefore important for maintaining glucose
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homeostasis [7]. It is well known that insulin stimulated glucose uptake in
muscle cells occur via the translocation of GLUT4 to the plasma membrane
[80]. A defect in GLUT4 activity or glucose transport eciency is also known
to result in the phenotype associated with insulin resistance [81]. Therefore,
glucose uptake in muscle cells depend on the insulin stimulated translocation
of GLUT4, however, the mechanism underlying GLUT4 translocation has re-
mained unclear. Various in vitro model systems have been developed to study
glucose uptake via GLUT4 in muscle cells. However, most of the established
skeletal muscle cell lines have shown little to no insulin response, with rat L6
and mouse C2C12 myotubes being the only two exceptions [82]. Upon insulin
stimulation, L6 myotubes seems to display glucose uptake to a greater extent
than C2C12 myotubes [83]. This suggests that L6 myotubes might be the best
available in vitro model system for studying insulin stimulated glucose uptake
in muscle cells [84].
2.6 Systems Biology
Advancements in the elds of molecular biology and biochemistry have led to
the discovery of complex signaling interactions occurring between intra- and ex-
tracellular biomolecules. Cell signaling pathways represent complex networks
which involve many shared components that are responsible for controlling
cellular responses to environmental changes. Various experimental approaches
exist to identify components of signalling networks as well as their biological
function. However, understanding how all these components t together in an
integrated manner can prove challenging [85]. A holistic approach to building
a better understanding of complex biological systems involves mathematical
and computational modelling, which can assist in the interpretation of data
and general biological understanding [86].
There are various modelling approaches utilised in cellular biochemistry,
however, models incorporating dierential equations coincide the best with
underlying biochemical rate laws [85]. Ordinary dierential equations (ODE)
can be used to describe chemical reactions of systems with a large number
of molecules. Partial dierential equations (PDE) allow the incorporation of
spatial gradients [85], and stochastic methods enable the analysis of systems
containing a small number of molecules [88]. Spatial and temporal dynamics of
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biochemical processes can be modelled in detail using networks of dierential
equations, which makes it possible to predict the behaviour of a network under
varied conditions. The model outputs of ODE- and PDE-based models are
largely dependent on the "free" parameter values and the interaction between
species needs to be specied beforehand. The estimation of parameters can
be a computationally intensive task for which a considerable amount of data
is necessary. ODE modeling becomes more complicated as networks expand,
which limits models that where initially designed to represent real biological
data to a small number of components [85].
2.6.1 Systems biology of the insulin signalling pathway
and T2D
Many models exist that describe parts of the insulin signalling pathway, with
some mathematical models even attempting to model entire pathways. How-
ever, these models often use dierent modelling approaches, as well as parts
of other models that were created in dierent environments and under var-
ious conditions. Some of these models also use parameter values obtained
from literature, from various research groups and various cell lines. Previous
models have described insulin binding to IR and receptor recycling [89, 90]
as well as regulation of GLUT4 in detail [91]. The Sedaghat model [92] is
the rst model to include signaling intermediates downstream from IR and
upstream of GLUT4 and included signalling intermediates IRS, PI3K, PKC-γ
and Akt. However, there are certain limitations in this model. The data used
to create this model is limited, obtained from dierent experimental setups
and parameter values seems to be chosen "somewhat arbitrarily" [93]. These
facts bring into question the validity of the model, and whether its predictions
are an accurate representation of the system it is trying to describe. Other
groups [94, 95] have used the Sedaghat model [92] as a basis for expanding
and including more signalling intermediates, however the results were either
not experimentally validated or parameters were either reused or assumed and
tted to a limited data set when compared to the complexity of the model
[93].
To our knowledge Brännmark et al. [96] were the rst to model the insulin
signalling pathway in T2D. Their model is ODE based and quantitatively
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describes the dynamics of the insulin signalling pathway. All the data were
obtained from primary human mature adipocytes from non-diabetic and T2D
patients. The model consists of dose-response, time course, and steady state
data all obtained from the same cell type. The data was also obtained in a
consistent manner which is important for the combination of data for systems
analysis. These types of data are important in elucidating complex mecha-
nisms, especially for mathematical modelling. The model was setup in such a
way that all the parameters were optimised to t both the non-diabetic and
diabetic state, except for the three diabetic parameters namely: reduced IR
concentration, reduced concentration of GLUT4 regulated by IR and lastly,
feedback from mTOR in complex with mTORC1. The diabetic parameters
were scaled according to the percentage concentration decrease in each of the
parameters. Overall they were able to construct a mathematical model of the
insulin signalling pathway for both diabetic and non-diabetic states in human
adipocytes. Obtaining a model for the non-diabetic state allowed them to
identify mechanistic dierences in the pathway for the diabetic state. Changes
were observed in almost all of the signalling intermediates, but they deter-
mined that this was due to the attenuation of a positive feedback mechanism
involving mTOR/mTORC1 and IRS1 [96].
Most models that exist on signalling networks are ODE based models. One
of the properties of signalling networks are that proteins are involved in more
than one reaction and have multiple post-translational modication sites [97].
Creating an ODE based model that can account for all these reactions can
become complicated and may be prone to errors. Rule-based models (RBM)
are an alternative approach for modelling signalling networks [97, 98]. RBM is
based on an assumption that reactions can be grouped together in one "rule"
and associated with the same rate law when they involve the same compo-
nents. The rules specied for a system can then be used to generate ODEs for
simulation [99]. Camillo et al. [97] made use of RBM to create a mathemat-
ical model integrating three existing models of signalling pathways, namely;
PI3K-Akt pathway, the RAS-ERK1/2 pathway and the TSC1/2-mTOR path-
way. This model used the Sedaghat model [92] for the PI3K-Akt pathway,
which has its own drawbacks as mentioned previously. This model was only
partially validated with experimental data of one signalling intermediate for
each of the three pathways. However, this might be the rst model to account
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for the complexities of signalling networks, specically the insulin signalling
pathway. This RBM based model could serve as a useful tool for generating
new hypotheses and may allow for the easy inclusion and integration of new
mechanisms as they are made available [97].
In summary, there are a variety of models available in literature. These
models either describe parts of the insulin signalling pathway or attempt to
model the whole pathway with parameters obtained from various sources. To
our knowledge, there are no other models that depict the insulin signalling
pathway under T2D conditions or in T2D patients, except for Brännmark et
al. [96]. Therefore the Brännmark et al. model serves as a starting point
for modelling the insulin signalling pathway in both diabetic and non-diabetic
states. None of these models link insulin signalling to glucose transport, and





All abbreviations can be found in the Nomenclature.
Materials: All reagents were obtained from Sigma-Merck unless stated oth-
erwise.
Cell culturing Rat L6 muscle myoblasts were grown in 4.5g/L DMEM sup-
plemented with 10% FBS v/v and incubated at 37°C and 5% CO2. Cultures
were refreshed every two days. When the conuence reached 80% cultures
were passaged into multiple asks and dishes. The cells were subcultured
equally into T75 asks and 100mm culture dishes. Once the cells reached 80%
conuence they were dierentiated with dierentiation media (4g/L DMEM
supplemented with 2% v/v HS). Cells were then refreshed every two days with
dierentiation media until they have developed into myobers. The dierenti-
ated cells were subsequently used in all experiments. Cells were serum starved
overnight in 1g/L DMEM and then glucose starved for 3-4 hours with PBS
supplemented to 1mMMgCl2 and CaCl2 prior to all experiments (unless stated
otherwise). All cell culture photos were taken with an Evos XL Cell Imaging
System (Thermo Fisher Scientic).
Insulin Response Assays Insulin (100nM) was added to all the 100mm
dishes containing supplemented PBS, and cells were harvested at dierent
time points for time response assays and at dierent dosages for dose response
assays. Dephosphorylation experiments were performed in a similar manner,
except the insulin was washed away after 30min and cells were starved for the
22
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respective time points. Cells were harvested by discarding the PBS containing
insulin and adding 500µl of 1x lysis buer (10x Lysis buer((250mM Tris/HCL
pH 7.4, 1.5M NaCl, 1% SDS, 10% Triton X-100)), 1 x phosstop tablet/10mL,
1 x cOmplete EDTA free protease inhibitor tablet/10mL, 10% deoxycholate
and MiliQ water) after which the cells were harvested with a scraper and put
into Eppendorf tubes. These samples were stored at -80°C for further western
blot analyses.
SDS Page andWestern Blot Analyses Samples were spun down at 20817
x g for 15min, after which the supernatant was aspirated and aliquoted in
new Eppendorf tubes. Laemeli Sample buer (4x) (Biorad) and Dithiothreitol
(DTT) were added in the ratio of (400µl : 100µl) to the supernatant to keep
the protein phosphorylation stable. Samples were immediately analysed as to
prevent loss of phosphorylated proteins. Samples were loaded on an 8% gel and
electrophoresed at 25mA per gel with a 10x SDS Running Buer. Afterwards
the proteins were transferred to a Polyvinylidene uoride (PVDF) membrane
(Biorad) at 20V overnight with a transfer buer containing 50mM Tris, 380mM
Glycine, 0.1% SDS and 20% methanol. Following the transfer, one membrane
was used to visualise the total protein and the other mebrane was used to
visualise phosphorylated proteins. The membrane was also blocked in 5% fat
free milk for two hours before incubation in primary antibody. The membranes
were cut at 250kDa, 100kDa, 75kDa and 50kDa respectively and the membrane
strips were placed in dierent primary antibodies overnight at 4°C. After the
primary antibody incubation the membrane strips were washed with 1 x TBS-
T buer (100mL 10 x TBS (200mM Tris base and 1.5M NaCl) in 900mL MiliQ
with 1mL Tween-20) for 1min, 5min and 15min respectively after which it was
incubated for one hour in 1µL secondary antibody: 10mL 5% fat free milk
(TBS-T was used to dilute the milk to a concentration of 5%). Following the
incubation with secondary antibody, the membranes were washed as before.
Blots were visualised using Clarity Western ECL Substrate (Biorad) and the
Thermo Scientiic myECL Imager. ImageJ was used to analyse the western
blot images by producing intensity peaks for each band, and then determining
the area under the peak. ImageLabwas used to determine normalisation
factors from images of the SDS Page gels.
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Table 3.1: A summary of primary- and secondary antibodies used
during western blot analyses
Primary Antibodies Ab no Company
Akt total 9272 Cell Signalling Technology
Akt1 (S473) phos 81283 Abcam




14C glucose transporter activity assays Cells were serum starved overnight
in low glucose DMEM and then glucose starved for 3-4 hours with PBS sup-
plemented to 1mM MgCl2 and CaCl2. Cells were pre-incubated with 100nM
insulin for 30min. The PBS was aspirated and cells were refreshed with 10mL
low glucose DMEM containing 1µCi/mL radiolabelled glucose. After two sec-
onds the media was removed and cells were washed with quenching buer
(cold PBS containing 500mM glucose) twice. Thereafter the cells were har-
vested with a lysis buer (50mM Tris, 150mM NaCl and 1% Triton X-100)
and 100µl of the sample was added to a vial containing 5mL ScintFlo II and
read by Tri-Carb 2810TR Liquid Scintillation Analyzer (PerkinElmer).
Data Analysis and Mathematical Modelling Microsoft Excel and Wol-
fram Mathematica® were used for all data analysis and modelling. The nonlin-
earmodelt function in Wolfram Mathematica® was used to t for the param-






As stated in Chapter 1 we set out to characterise the eects of time and
varying insulin doses on the insulin signalling pathway. Tissue culturing and
western blot analysis are commonly used to investigate the insulin signalling
pathway [15, 100103]. However, the type of information available in literature
is mostly qualitative, i.e. phosphorylated or not, and does not have detail on
time and dose response, nor on a mathematical model describing this data.
In our opinion, such data and a model are important to compare normal cells
with diseased cells, and we therefore set out to characterise a reference model
for rat L6 muscle cells.
Initially, our focus was on IR, IRS and Akt as they were the three main
nodes identied that lead to the activation of the insulin signalling pathway,
resulting in GLUT4 movement to the membrane, but as described in section
4.2.2 we had diculties quantifying IR and IRS.
In this chapter we present results for the phosphorylation, dephosphory-
lation and dose-dependent behaviour of Akt Ser473 and Thr308 in a reference
(non-diabetic) state. We use these results to create a model that can describe
this behaviour, and that can be used to compare with a model created with
data obtained under diabetic conditions. This could lead to insights into the
disease mechanisms of insulin resistance and by extension, Type 2 diabetes.
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4.2 Optimization of experimental procedures
4.2.1 Cell culturing
In this study the L6 rat skeletal muscle cell line was used for all experiments.
The muscle cells were seeded in T75 culturing asks containing DMEM (1g/L
glucose) and initially augmented with 200 g/L glucose to yield a nal glucose
concentration of 10-11 mM, (medium glucose DMEM) in accordance with a
similar protocol developed in a prior study involving C2C12 muscle cells (un-
published work by S. Kuhn). However, this protocol could not be followed for
the L6 cells due to the following problems: Cells grew too slow and formed
dierentiating clusters before reaching conuence, notable quantities of debris
were observed under the microscope, the cells also started to dislodge from the
culture plates during dierentiation (See Fig. 4.1 (a) & (b)). We optimised
a growth and dierentiation protocol for L6 cells, which included: switching
growth medium from DMEM containing ± 10mM glucose to DMEM contain-
ing 25mM glucose, seeding in a T25 ask instead of a T75 ask and adjusting
the splitting protocol to lower the number of asks each T75 was split into
(see Fig. 4.2). A summary of the changes made to the L6 culturing protocol
can be found in table 4.1.
4.2.2 Western blotting
To determine the total- and phosphorylated protein levels of IR, IRS and Akt
for L6 cells a protocol developed in our lab for the C2C12 cell line was followed
(unpublished work by T. Kouril). Repeating this protocol with L6 samples did
not yield the same results. IR provided a smear on the blot using a general
anti-phosphotyrosine antibody (abcam # 179530) and did not seem to show a
dierence between samples unstimulated and stimulated with insulin. Using
the same general anti-phosphotyrosine antibody for IRS, multiple bands were
observed in the size range of approx. 100 - 250 kDa, making it dicult to
acertain which bands were actually IRS. In addition, no insulin response was
observed for these samples.
There were no diculties detecting Akt Ser473 phosphorylation with this
protocol using anti-AKT1 (phospho S473) antibody (abcam # 81283). How-
ever, we were not able to detect bands on the blots for Akt Thr308 phosphory-
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(a) (b)
(c) (d)
Figure 4.1: Cell culture photos of L6 muscle cells. Figures (a) and (b) are
dierentiated L6 muscle bers that have started lifting o the culture dishes.
It can be seen that the bers appear to be thin and more elongated with
notable quantities of cell debris clearly visible. Figure (c) shows growing L6
myoblasts almost ready for dierentiation. Figure (d) shows dierentiated L6
myobers, which are formed when myoblasts align and fuse to form thick and
long muscle bers.
lation with the anti-AKT1 (phospho T308) antibody (abcam # 105731). The
total protein for IR and Akt were successfully detected, with the total levels
remaining constant in all samples, including those stimulated with insulin. IRS
total protein, however, also resulted in many dierent bands but at dierent
sizes compared to the phosphorylated IRS bands, which provided diculties
in identifying which bands were IRS.
To reduce the background for the phosphorylated IR protein we tried us-
ing a dierent primary antibody Anti-Insulin Receptor beta (phospho Y1185)
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Figure 4.2: Passaging protocol for L6 myoblasts. L6 myoblasts were
seeded from freezerstock into a T25 ask, once the cells were 70-80% conuent
they were passaged into one T75 ask. When the T75 ask reached the same
conuence it was split into three T75 asks. Each of the three T75 asks
were passaged into two T75 asks, reulting in six T75 asks. Once these six
asks were 70-80% conuent, they were each passaged into ve 100mm cultures
dishes respectively.
(abcam # 203278), that is specic for a phosphorylation site on IR (Y1185).
This antibody produced an even weaker signal than the rst antibody and the
smear in the lanes was not cleared up. Another general anti-phosphotyrosine
antibody (Cell Signalling Technologies # 9411) was tested and resulted in
higher background than the previous general antibody. Adjusting the concen-
tration of the primary antibody (abcam # 179530) from (1:1000 µl) to (1:500
µl) to (1.5:500 µl) did not improve the strength of the signal either. Switching
reducing agents from DTT to β-mercaptoethanol (BME) was also unsuccess-
ful in clarifying the smear observed for phosphorylated IR protein. Our last
eort was to try and switch membranes from PVDF to nitrocellulose, but
this did not reduce the smear. Due to a lack of BSA availability, 5% fat-free
milk was used as a blocking agent. However, this did not improve the blots
for phosphorylated IR and IRS. None of these changes improved the smear
for the phosphorylated IR blots, nor did they improve the ability to distin-
guish between the various phosphorylated IRS bands (Refer to Appendix A
for examples of these results).
This was in stark contrast to phosphorylated AKT Ser473 which was always
relatively easy to detect. Thus, it was decided to focus on Akt. It is known
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Table 4.1: Summary of L6 culturing conditions:
Conditions
C2C12 (unpublished
protocol by S. Kuhn)
L6 (this project)







Refresh Media Every two days Every two days
Initiate
dierentiation









5-6 days 3-4 days
that both Ser473 phosphorylation and Thr308 is necessary for full activation of
Akt [100], therefore, we attempted to detect the Thr308 site once more. A new
antibody Phospho-Akt (Thr308) (Cell Signalling Technologies #13038) was
used for this attempt, which resulted in the successful detection of the Thr308
site. These experimental diculties limited the number of signal transduction
components that could be detected in the L6 cells, but we could still resolve the
initial trigger (insulin) and the nal output (Akt) for both its phosphorylation
sites.
Stellenbosch University https://scholar.sun.ac.za
CHAPTER 4. RESULTS 30
4.3 Measuring Akt Ser473 ,Thr308
phosphorylation dynamics and GLUT4
transporter activity
In this section we set out to investigate the phosphorylation dynamics of AKT
in a time- and dose dependent manner via western blot analysis. Two Akt
phosphorylation sites were investigated namely Ser473 and Thr308 . As far
as we know, there is limited information in literature on the time and dose
dependent behaviour of any of the signalling intermediates. In this study we
attempted to elucidate the time and dose dependent behaviour of both Akt
sites.
4.3.1 Akt Ser473 and Thr308 phosphorylation
L6 muscle cells were grown until fully dierentiated, serum and glucose starved,
after which they were exposed to 100nM insulin. The dishes were harvested
at the indicated time points, and further analysed via western blot. Once the
result from the western blots were obtained, ImageJ was used to determine the
intensities of the bands, which was normalized with normalization factors ob-
tained from ImageLab. The normalized intensities were plotted against time
to show time dependent phosphorylation for both the Ser473 and Thr308 site.
In Fig. 4.3 (a) there is a relatively fast induction of Ser473 phosphorylation
compared to Fig. 4.3 (b) which shows a slower induction of Thr308 phospho-
rylation. The total Akt levels (Fig. 4.3 (c)) stay constant with no induction
visible between unstimulated and stimulated samples. All levels are expressed
relative to the 30min incubation with a 100nM insulin, which was set to 1.
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Figure 4.3: Time dependent
phosphorylation of Akt. Cells
were incubated with 100nM insulin
and harvested at dierent time-
points. Each sample was probed
with specic Akt Ser473 , Thr308
and total antibody. The antibody
signal was plotted against time for
Akt Ser473 (a), Akt Thr308 (b) and
Akt total (c). Results are means of
three experiments ± SE and nor-
malised to the 30min timepoint.
4.3.2 Akt Ser473 and Thr308 dephosphorylation
To create a model that can acurately describe the time dynamics of Akt phos-
phorylation, it is important to also investigate the dephosphorylation dynamics
of the protein. This experiment was performed similarly to the phosphoryla-
tion experiment. L6 muscle cells were grown until fully dierentiated, serum
and glucose starved, after which they were incubated with 100nM insulin for
30min. After the 30min incubation the cells were washed twice with PBS, and
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then incubated with unsupplemented PBS, to determine how fast the Ser473
and Thr308 site dephosphorylates. In Fig. 4.4 (a) the Ser473 site dephospho-
rylates faster than the Thr308 site seen in Fig. 4.4 (b). The total Akt for
the dephosphorylation experiment remained constant (Fig. 4.4 (c)) with no
decrease in signal when insulin is washed away.









































Figure 4.4: Time dependent de-
phosphorylation of Akt. Cells
were incubated with 100nM insulin
for 30min after which the insulin
was removed at dierent timepoints
and harvested. Each sample was
probed with specic Akt Ser473 and
Thr308 antibodies as well as with a
total Akt antibody. The antibody
signal was plotted against time for
Akt Ser473 (a), Akt Thr308 (b) and
Akt total (c). Results are means of
three experiments ± SE and nor-
malised to the 1min time point.
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4.3.3 Akt Ser473 and Thr308 dose dependent
phosphorylation
The dose dependent behaviour of Akt Ser473 and Thr308 sites were also in-
vestigated by stimulating the cells with dierent doses of insulin for 30min.
The dose response for the Ser473 and Thr308 site showed similar responses to
the various insulin concentrations (as seen in Fig.4.5 (a) and (b)) with a lin-
ear increase as insulin concentrations increase. The level of total expression
of Akt remained constant with no visible increase in concentration as insulin
concentration increased (Fig. 4.5 (c)).











































Figure 4.5: Dose dependent
phosphorylation of Akt. Cells
were incubated with various insulin
concentrations and harvested after
30min. Each sample was probed
with specic Akt Ser473 and Thr308
antibodies as well as with a total
Akt antibody. The antibody sig-
nal was plotted against time for
Akt Ser473 (a), Akt Thr308 (b) and
Akt total (c). Results are means of
three experiments ± SE and nor-
malised to the 100nM insulin con-
centration.
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4.3.4 GLUT4 transporter activity
A two-second radiolabled glucose assay was performed, as described in chapter
3, to elucidate the transporter behaviour when the cells are stimulated with
insulin. Assuming that GLUT1 is constitutively expressed this transporter
will be responsible for basal glucose uptake. Upon insulin stimulation GLUT4
will be signalled, via Akt phosphorylation, to translocate to the membrane.
Cells were stimulated with 1nM and 100nM insulin for 30min respectively,
after which the two-second assay was performed. From Fig. 4.6 it is clear that
there is an increase in glucose uptake rate when stimulated with insulin, with a
2x maximal induction when stimulated with 100nM insulin compared to basal
uptake. This is similar to what has been reported in literature [104] which































Figure 4.6: GLUT4 transport activity stimulated with 1nM and
100nM insulin for 30min. Results are means of three experiments ± SE.
Between the control sample (not stimulated with insulin) and the sample stim-
ulated with 1nM insulin there is a 1.46-fold induction (P<0.05*). Similarly
there is a 1.91-fold (P<0.05*) induction between the sample stimulated with a
100nM insulin and the control. It was also determined that there was a 1.29-
fold (P<0.05*) increase between the sample stimulated with 1nM and 100nM
insulin. (*t-test: Two-Sample Assuming Equal Variances)
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4.3.5 Summary
We were able to quantify the dose dependent phosphorylation as well as the
time dependent phoshorylation and dephosphorylation for both Akt Ser473 and
Thr308 sites. The glucose uptake rate was also determined for two dierent
insulin concentrations. Next we will use the data presented in this section,
which was obtained under non-diabetic conditions, to construct a model that
can describe the time- and dose dependent behaviour of Akt in response to
insulin. For each data set the level of total Akt was determined. In the
following section all phosphorylation data sets are normalised to its respective
total.
4.4 Modelling the phosphorylation dynamics of
Akt Ser473 and Thr308
4.4.1 Model Setup
A model was constructed to mathematically describe the time dependent and
dose dependent phosphorylation of Akt as a function of insulin. The extent of
Akt phosphorylation of the Ser473 and Thr308 sites, obtained by western blot
analyses, was correlated to insulin treatment of dierentiated L6 cells. Due to
a lack of IR and IRS phosphorylation data, the model directly correlates Akt
phosphorylation to insulin action. It is of interest to see whether the model can
accurately describe the Akt phosphorylation and dephosphorylation kinetics
in the absence of intermediary reactions.
The analysis for Akt Ser473 and Thr308 are the same and therefore we
will show only the equations for the Ser473 site. Total Akt can be described
as aktST = aktS(t) + aktSp(t) where the unphosphorylated form (aktS(t))
and phosphorylated form (aktSp(t)) are added to give total Akt (aktST ). The
phosphorylated form aktSp(t) is a dependent variable which is modelled as the
total concentration of the component (aktST ) minus the independent variable
(aktS(t)).
Stellenbosch University https://scholar.sun.ac.za
CHAPTER 4. RESULTS 36
In the presence of insulin Akt is phosphorylated at a rate of kp and in the





Figure 4.7: Reaction scheme of the phosphorylation of Akt used for
the derivation of kinetic equations.
We are interested in modelling the appearance of phosphorylated Akt over
time (aktSp(t)), which can also be described as the dissapearance of the un-
phosphorylated form of Akt (aktS(t)) (Forward reaction in Fig. 4.7. With
this information and the reaction scheme we can use mass action kinetics to
describe the phosphorylation and dephosphorylation process:
daktS(t)
dt
= −ins · kpaktS · aktS(t) + kdpaktS · (aktSp(t)) (4.4.1)
Total Akt (aktST ) is equal to the sum of the phosphorylated (aktSp(t)) and
unphosphorylated form of Akt (aktS(t)), we can therefore write the following
expression:
aktSp(t) = (aktST − aktS(t)) (4.4.2)




= −ins · kpaktS · aktS(t) + kdpaktS · (aktST − aktS(t)) (4.4.3)
4.4.1.1 Using steady state constraints for insulin dose response
analysis
To estimate the parameters for the phosphorylation and dephosphorylation
we use a dose response experiment to determine steady state phosphorylation
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levels. This allows for the estimation of the ratio
kdpaktS
kpaktS
as well as the total
amount of Akt (aktST ). Steady state is assumed to be reached at 30min with
an insulin concentration (100nM), and this is normalized to 1. Under steady
state the following can be derived for aktS(t):
0 = −ins · kpaktS · aktS(t) + kdpaktS · (aktST − aktS(t)) (4.4.4)
aktS =
kdpaktS · aktST







When there is no insulin present (ins = 0) then the unphosphorylated form








Eq 4.4.6 can be simplied to:


















aktSp(t) = aktST − aktS(t) (4.4.9)
Then Eq. 4.4.7 and Eq. 4.4.8 can be substituted into Eq. 4.4.9. This leads
to the nal equation:
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(See Fig. 4.8 and Table 4.2 for parameter estimations).
In Fig. 4.8 (a) and (b) the modelt shows a hyberbolic trend compared to
the data which seems to be linear. As the model approaches approximately
0.8, it starts to reach a plateau before the highest tested insulin concentration
(100nM).


































Figure 4.8: Model t to Akt Ser473 an Thr308 phosphorylation as a
function of insulin. Western blot analysis was used to quantify the phos-
phorylation levels for both the Ser473 and Thr308 site. Cells were incubated
for 30min with the respective concentrations and values were normalized to
100nM insulin, which was considered steady state phosphorylation. Eq. 4.4.4
was tted to experimental data for Ser473 and Thr308 . Data was normalised
to their respective total.
4.4.2 Insulin time response
The ratio obtained from the dose response t (Fig. 4.8 and Table. 4.2) was
substituted into Eq. 4.4.3. This equation was then used to simulate both
the Ser473 and Thr308 phosphorylation and dephosphorylation timecourses to
determine if the model could describe the experimental data (Fig. 4.3 & 4.4).
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Table 4.2: Kinetic parameters for the steady state rate equations.












































Figure 4.9: Phosphorylation and dephosphorylation data for the
Ser473 (a) and Thr308 (b) site shown with the modelt. The data
was obtained via western blot analyses by stimulating myobers with a 100nm
insulin for the respective time points and then washing away insulin to de-
termine the dephosphorylation. The data is shown in blue with the modelt
shown as a blackcurve.
From Fig. 4.9 it is clear that the model description for the Ser473 and Thr308
phosphorylation is fairly good, with the phosphorylation of Thr308 site being
slower compared to the Ser473 site. The model was also able to describe the
dephosphorylation dynamics of both sites fairly well with the dephosphoryla-
tion of the Ser473 site being slightly faster than that of the Thr308 site. This
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could also be determined mathematically by calculating how long it takes for
the sites to reach half of the maximal phosphorylation (tp0.5) or dephospho-
rylation (tdp0.5). The ODE for aktS(t) could be used to determine the time
it takes for the phosphorylation of the Ser473 site to reach 0.5.
It was determined that tp0.5 = 0.99min for the Ser
473 and tp0.5 = 3.57min
for the Thr308 site. Therefore, upon insulin stimulation, the Ser473 on Akt is
phosphorylated 3.6x faster than the Thr308 site. To determine the tdp0.5 for







ekt0.5 = 2 (4.4.12)





In this case k from Eq. 4.4.14 is kdp for either Akt Ser473 or Thr308 site.







now need to determine kdpaktS and kdpaktT by substituting estimated values for
kpaktS and kpaktT .
From the model it is estimated that kpaktS = 0.0068min
-1 and kpaktT =
0.0019min-1. We can thus calculate that kdpaktS = 0.0188min
-1 and kdpaktT =
0.00483min-1. These values can be substituted into Eq. 4.4.14 to calculate
tdpS0.5 = 36.8min and tdpT0.5 = 143.5min. Therefore, upon insulin removal,
the Thr308 site dephosphorylates 3.8x slower than the Ser473 site.
4.4.3 Linking glucose transport to signalling
Akt phosphorylation has been identied as the main component responsible
for signalling GLUT4 to translocate from the cytosol (glutC(t)) to the mem-
brane [20]. The movement of the transporter to the membrane (glutM(t))
was measured through a two-second radiolabelled glucose assay. Mass action
kinetics, similar to that of the Ser473 and Thr308 phosphorylation, was used for
linking Akt phosphorylation to glucose transport. If we assume that the total
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transporter concentration stays constant then glutT = glutM(t) + glutC(t)
and glutM = glut4 + glutB . Here glutB represents the basal transport level



















(aktST − aktS) · glutT + kout
kin
· glutB




glutT = (1 +
kout
kin




Eq. 4.4.19 and Eq. 4.4.20 was tted to the dose response data (Fig. 4.5)
of Akt Ser473 and Thr308 phosphorylation and GLUT4 activity (Fig. 4.10).
glutMmax was set to 6713.44 nmol/min/mg at a phosphorylation level of 1 for
Akt (30min incubation with 100nM insulin) and basal glucose uptake (glutB)
was set to 3561.12 nmol/min/mg which was the uptake when no insulin was
added (Fig. 4.6). The values for glutMmax and glutB were obtained from our
dose response experiment in Fig. 4.6.
There is a hyperbolic relationship between glucose transport and phospho-
rylated Akt Ser473 and Thr308 as seen in Fig.4.10 (a) and (b). The model t
corresponds well with the experimental data and it seems to be the same for
both phosphorylation sites.
Stellenbosch University https://scholar.sun.ac.za
CHAPTER 4. RESULTS 42






















































Figure 4.10: Glucose transport activity as a function of Akt Ser473 (a)
and Thr308 (b) phosphorylation when stimulated with insulin. Cells
were stimulated with various concentrations of insulin for 30min, Akt Ser473
and Thr308 phosphorylation were measured via western blot analysis. The
phosphorylation levels were normalised to the phosphorylation level obtained
with a 100nM insulin. A two-second radiolabelled glucose assay was used to
determine the glucose transporter activity.
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Discussion, Future work and
Conclusions
5.1 Discussion
T2D is a complicated metabolic disease that involves various organs and bi-
ological processes in the body. It is known that T2D patients suer from
hyperglycemia and hyperinsulinemia, but the biochemical processes that lead
to these physiological states is still unclear. The main tissues responsible for
maintaining glucose homeostasis in the body are muscle cells, adipocytes and
the liver. Therefore eorts should be focused on investigating the insulin sig-
nalling pathway in these tissues for clarication on the molecular mechanisms
that maintain glucose homeostasis. Furthermore, despite numerous studies
surrounding the insulin signalling, it remains unclear how the intermediates
in the pathway respond to insulin over time or even at higher concentrations
of insulin. One method to study these pathway responses would be the con-
struction of mathematical models to predict the outcomes of these changes.
Mathematical models can help us understand complex systems and how they
t together, as well as identify possible drug targets. Due to the complexity of
the insulin signalling pathway we set out to build a mathematical model that
can describe the behaviour of its intermediates over time.
This study focused on characterising the dynamic behaviour of Akt in a
time and dose dependent manner as well as investigating the glucose uptake
rate in L6 skeletal muscle cells with the ultimate goal of creating a mathemat-
43
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ical model of the reference "healthy" state that can describe this behaviour.
It was important during this study to dene and optimise the culturing con-
ditions. This was a time consuming process, but was important for ensuring
that there was consistency between dierent culture sets.
Due to the complexity of the insulin signalling pathway we were not able
to quantify all of the intermediates of the pathway. However, we were able to
quantify the time and dose dependent behaviour of two phosphorylation sites
on Akt (Ser473 and Thr308 ) and establish the glucose uptake rate for L6 cells
at two dierent insulin concentrations. The phosphorylation of Akt increased
over time for both Ser473 and Thr308 sites and decreased over time when insulin
was removed. This allowed us to determine that the phosphorylation levels
reached steady state at 30min when exposed to 100nM insulin. The dose
dependent behaviour of both sites was monitored for 30min at various insulin
concentrations.
We know that Akt signals GLUT4 to translocate to the membrane where
it will import glucose into the cell. In an attempt to link glucose transport to
Akt the time and dose dependent behaviour of GLUT4 was also investigated.
However, we were not able to determine the time dependent behaviour of
GLUT4 and could only determine the rate of glucose uptake at two dierent
insulin concentrations.
Next we used ODEs to create a mathematical model describing the insulin
signalling pathway in L6 cells. The model was tted on the dose response data







The tted parameters were then used in the model to determine if the model
could accurately describe the timecourse data for the Akt sites. The ratio was
tted on the steady state and therefore constrained to the steady state t (Fig.
4.8).
Even though the model t for the steady state does not follow the trend
of the data accurately, the model was still able to describe the time course
data well with the ratio obtained from the steady state t (Fig. 4.9). We were
also interested in determining the dierence between the phosphorylation sites
when it came to the time it took for each site to become half maximally phos-
phorylated. We could mathematically determine that the Ser473 site phospho-
rylates 3.6x faster and dephosphorylates 3.8x faster compared to that of the
Thr308 site.
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Next we linked the dose behaviour of Akt to the dose behaviour of GLUT4
by plotting phosphorylated Akt versus GLUT4 uptake rate. The model t
follows the data closely in a hyperbolic manner indicating that as the phos-
phorylation of Akt increases so does the transporter activity of GLUT4. No
dierence was found for the steady state relation between AktSp and AktTp
and transport activity.
It is well known that insulin is an oscillating hormone, meaning that for
a period of time cells are exposed to insulin and a period of time it is not.
When insulin binds the IR it sets o a phosphorylation cascade namely the
insulin signalling pathway. However, in the absence of insulin these phos-
phorylated proteins in the cascade are dephosphorylated and are ready to be
phosphorylated when the next insulin spike occurs. It would seem that this
dephosphorylation would be of importance to investigate, but most studies
only look at the phosphorylation state of proteins.
There are mathematical models on signalling pathways for example Kholo-
denko et al. [105, 106] which include both the phosphorylation and dephos-
phorylation of certain reactions in their model. In the rst model Kholodenko
et al.[105] gives a kinetic description of signalling via the Epidermal Growth
Factor Receptor (EFGR). In this model they include the dephosphorylation
of EFG:EFGR complex. In the second model [106] they give a kinetic de-
scription of the mitogen-activated protein kinase (MAPK) cascade including
dephosphorylation reactions for MAPK and the MAPK kinases. The EFGR
model includes some data for the dephosphorylation, but lacks resolution over
time. The dephosphorylation reactions in MAPK model is not based on exper-
imental data. This might be due to the lack of such dephosphorylation data
at the time.
It seems like common practice for mathematical models to include dephos-
phorylation reactions in their kinetic descriptions, however these are not vali-
dated by experimental data. This is limiting for models based on ODEs that
describe the behaviour of proteins over time, but does not include how these
proteins behave when the activating molecule, in our case insulin, is removed.
This dephosphorylation behaviour is also important when considering condi-
tions such as insulin resistance and T2D where insulin is present at elevated
levels, or omnipresent. As the dissapearance of insulin allows for dephospho-
rylation to happen, an elevated level or a consistent level of insulin will change
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the dynamics of dephosphorylation in the signalling pathway.
One model that does however include dephosphorylation dynamics is the
model of Bränmark et al. [96]. As mentioned previously in section 2.6.1
this model made use of adipose tissue obtained from non-diabetic and dia-
betic subjects, and quantied signalling intermediates of the insulin signalling
pathway in a time and dose dependent manner. Their systematic approach
allowed them to compare dierences between the non-diabetic and diabetic
model, leading to their discovery of a feedback mechanism that accounts for
the changes observed between the two models, oering a possible mechanism
for insulin resistance at a cellular level. We aim to apply a similar approach in
muscle cells that could possibly elucidate cellular mechanisms for insulin resis-
tance. In our model setup we would create similar plots to that in Fig. 4.8 and
4.10 for the diabetic state. This will allow us to distinguish between changes
in insulin signalling and changes in glucose transport induction between the
reference and diabetic state.
In this study we aimed to construct a quantitative description of the insulin
signalling pathway and how this is linked to glucose transport by addressing
four objectives. Firstly, we investigated the two phosphorylation sites on Akt
(Ser473 and Thr308 ) at varying insulin concentrations to determine a dose
response for these sites. Secondly, the phosphorylation and dephosphorylation
of these two sites were quantied over time. Thirdly, we tested the transport
dynamics of GLUT4 over time, but could only quantify the transporter activity
for the basal- and stimulated conditions (1nM and 100nM insulin). These data
allowed us to address our nal aim to construct a mathematical model that
describe components of the insulin signalling pathway.
Future research: As mentioned before there are three compartments we
are interested in investigating for the model, namely: insulin signalling, glu-
cose transport and glucose metabolism. In this study we only investigated
Akt Ser473 and Thr308 phosphorylation sites and started initial investigations
into GLUT4 kinetics for the reference state. Future studies should focus on
quantifying the reference state of more intermediates in the insulin signalling
pathway, especially those highlighted in chapter 2 as they have been shown
to play important roles in the pathway. It is also important to extend the
data on GLUT4 to include time course data as well as more resolution on
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its dose dependent behaviour as we were not able to elucidate this behaviour
in the current study. These components can then be incorporated into the
model we created in section 4.4 for the reference state, which could bolster
the accuracy of the predictions obtained from the model. Glucose metabolism
also needs investigation under reference conditions before moving on to studies
in a "diabetic state". The next step should include investigating the insulin
signalling intermediates, glucose transport and glucose metabolism under "di-
abetic" conditions for the purpose of creating a model for the diabetic state.
This can be achieved by growing cells in high glucose and insulin. This will
hopefully allow us to compare the reference state model with the diabetic state
model to identify where the dierences lie between the two states.
5.2 Conclusion
Although we were not able to quantify IR and IRS we were able to look at
the rst and last components of the insulin signalling pathway, insulin and
Akt as well as GLUT4. This allowed us to create a quantitative model that
could predict the time dependent behaviour of Akt Ser473 and Thr308 phos-
phorylation as a function of insulin as well as linking Akt phosphorylation and
glucose transport. We found that the model descriptions correlated quite well
with the experimental data despite the lack of data on intermediates between
insulin and Akt. This model can be used as a starting point for future studies
investigating the insulin signalling pathway in both the reference- and diabetic
state. To the best of our knowledge this model represents the rst attempt to
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Nitrocellulose membrane: 
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